Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Ikeda

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 2, 2014
Prevalence and clinicoradiological analyses of patients with Alzheimer disease coexisting multiple microbleedsJunpei Nagasawa, Tetsuhito Kiyozaka, Ken Ikeda
Journal of the Neurological Sciences|May 19, 2015
Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosisKen Ikeda, Yasuo Iwasaki, Ryuji Kaji
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 4, 2010
Olmesartan, an angiotensin II receptor blocker, restores cerebral hypoperfusion in elderly patients with hypertensionRiya Nagata, Kiyokazu Kawabe, Ken Ikeda
Journal of the Neurological Sciences|September 8, 2009
Do serum uric acid levels reflect oxidative stress in the progression of ALS?Ken Ikeda, Kiyokazu Kawabe, Yasuo Iwasaki
Neurology|July 2, 2008
Re: Gout and risk of Parkinson disease: a prospective studyYasuo Iwasaki, Osamu Kano, Ken Ikeda
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 15, 2008
Different variables between patients with left and right hemispheric ischemic strokeHirono Ito, Osamu Kano, Ken Ikeda
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosisYasuo Iwasaki, Ken Ikeda, Masao Kinoshita
Neurology|October 24, 2012
Clinical features of Parkinson disease when onset of diabetes came first: a case-control studyKiyokazu Kawabe, Ken Ikeda, Yasuo Iwasaki
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 14, 2010
Clinicoradiologic features of vertebrobasilar dolichoectasia in stroke patientsYoshikazu Nakamura, Takehisa Hirayama, Ken Ikeda
Life Sciences|December 9, 2003
Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cellsSeiji Kobayashi, Ken Ikeda, Keiji Miyata
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 2, 2014
Prevalence and clinicoradiological analyses of patients with Alzheimer disease coexisting multiple microbleedsJunpei Nagasawa, Tetsuhito Kiyozaka, Ken Ikeda
Journal of the Neurological Sciences|May 19, 2015
Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosisKen Ikeda, Yasuo Iwasaki, Ryuji Kaji
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 4, 2010
Olmesartan, an angiotensin II receptor blocker, restores cerebral hypoperfusion in elderly patients with hypertensionRiya Nagata, Kiyokazu Kawabe, Ken Ikeda
Journal of the Neurological Sciences|September 8, 2009
Do serum uric acid levels reflect oxidative stress in the progression of ALS?Ken Ikeda, Kiyokazu Kawabe, Yasuo Iwasaki
Neurology|July 2, 2008
Re: Gout and risk of Parkinson disease: a prospective studyYasuo Iwasaki, Osamu Kano, Ken Ikeda
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 15, 2008
Different variables between patients with left and right hemispheric ischemic strokeHirono Ito, Osamu Kano, Ken Ikeda
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosisYasuo Iwasaki, Ken Ikeda, Masao Kinoshita
Neurology|October 24, 2012
Clinical features of Parkinson disease when onset of diabetes came first: a case-control studyKiyokazu Kawabe, Ken Ikeda, Yasuo Iwasaki
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 14, 2010
Clinicoradiologic features of vertebrobasilar dolichoectasia in stroke patientsYoshikazu Nakamura, Takehisa Hirayama, Ken Ikeda
Life Sciences|December 9, 2003
Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cellsSeiji Kobayashi, Ken Ikeda, Keiji Miyata
Pageof 16